耐万古霉素金葡菌及抗VRSA感染药物的研究进展  

Recent Progress on the Studies of Vancomycin-resistant Staphylococcus aureus and Anti-infection Medicine for VRSA

作　　者：顾觉奋[1] 李振国[1] 

机构地区：[1]中国药科大学生命科学与技术学院,南京210009

出　　处：《抗感染药学》2009年第2期73-76,共4页Anti-infection Pharmacy

摘　　要：近年来金黄色葡萄球菌对万古霉素的敏感性逐渐下降,并在各国相继出现了耐药菌株。根据国内外相关文献报道,笔者从耐万古霉素金黄色葡萄球菌(VRSA)的发现、耐药机制、治疗VRSA感染的药物等方面进行综述。In recent years, vancomycin sensitivity of the Staphylococcus aureus has been dropped gradually in the world, and the medicine-resistant strains appear one after another in various countries. The discovery, medicine mechanism and treatment of vancomycin-resistant Staphylococcus aureus（VRSA） were reviewed in this article.

关 键 词：金葡菌 万古霉素 耐药性 

分 类 号：R978.1[医药卫生—药品]